SCHEMBL11947252

SCHEMBL11947252

Cc1cc(-c2ccncc2)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(C=N)c1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 11/20 0.55
▸ CYP2C9 P11712 10/20 0.55
▸ KCNH2 Q12809 6/20 0.55
▸ CYP2D6 P10635 5/20 0.55
▸ CYP3A4 P08684 5/20 0.55
▸ CYP1A2 P05177 3/20 0.55
▸ ABCG2 Q9UNQ0 2/20 0.55
▸ ABCC3 O15438 1/20 0.55
▸ ESR1 P03372 1/20 0.55
▸ PGR P06401 1/20 0.55
▸ CHRM2 P08172 1/20 0.55
▸ ABCB1 P08183 1/20 0.55
▸ ADRA2A P08913 1/20 0.55
▸ CHRM1 P11229 1/20 0.55
▸ DRD1 P21728 1/20 0.55
▸ PTGS1 P23219 1/20 0.55
▸ SLC6A2 P23975 1/20 0.55
▸ ADORA1 P30542 1/20 0.55
▸ ABCC1 P33527 1/20 0.55
▸ OPRM1 P35372 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11946965 0.78 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2CYP2D6CYP3A4
SCHEMBL4100811 0.77 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2CYP2D6CYP3A4
SCHEMBL11947217 0.77 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2CYP2D6CYP3A4
SCHEMBL13798679 0.77 CYP2C19 (0.54) CYP2C19CYP2C9KCNH2CYP2D6CYP3A4
SCHEMBL4115999 0.77 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2CYP2D6CYP3A4
SCHEMBL4111673 0.76 CYP2C19 (0.50) CYP2C19CYP2C9KCNH2CYP2D6CYP3A4
SCHEMBL11947218 0.76 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2CYP2D6CYP3A4
SCHEMBL4098291 0.76 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2CYP2D6CYP3A4
SCHEMBL4105108 0.76 CYP2C19 (0.50) CYP2C19CYP2C9KCNH2CYP2D6CYP3A4
SCHEMBL4098676 0.76 CYP2C19 (0.50) CYP2C19CYP2C9KCNH2CYP2D6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220091-B1 REVERSE TRANSCRIPTASE INHIBITORS ARDEA BIOSCIENCES INC (US) 2012-07-25 — — EP disclosed
Send feedback